Korro Bio KRRO
NASDAQ KRRO
$9.91 +0.35 (+3.66%)
At close: Sep 30, 2026 · 4:00 PM EDT

Korro Bio (KRRO) Preferred Stock Liabilities (2018 - 2022)

Updated

Korro Bio's Preferred Stock Liabilities was $163.86 million in Q4 2022, unchanged from $163.86 million a year earlier.

Analysis

Korro Bio (KRRO) Preferred Stock Liabilities (2018 - 2022) Analysis & Trends

From Q4 2018 onward, Korro Bio has reported Preferred Stock Liabilities for 4 quarters.

  • Preferred Stock Liabilities shows a five-year compound annual growth rate of 51.1% (FY2017 to FY2022).
  • In earlier years, Preferred Stock Liabilities was $163.86 million in FY2021 and $84.94 million in FY2018 (+308.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Korro Bio 145.73 Mn -250.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 163.86 Mn
Dec 31, 2021 163.86 Mn
Sep 30, 2019 147.90 Mn
Dec 31, 2018 84.94 Mn
API Access

Korro Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=KRRO&period=max&api_key=YOUR_API_KEY